Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tim Porter
Observed names:
T. Porter,
TIM PORTER
Observed institutions:
University of Bristol,
Taunton & Somerset NHS Foundation Trust,
Centre Hospitalier de l’Université de Montréal,
Yeovil District Hospital
OpenAlex ID:
A5019760035
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
2023
·
Gerhardt Attard
, Laura Murphy
, et al.
·
The Lancet Oncology
·
120
PDF
The Effect of Erectile Dysfunction on Quality of Life: Psychometric Testing of a New Quality of Life Measure for Patients With Erectile Dysfunction
2002
·
RUARAIDH MacDONAGH
, PAUL EWINGS
, et al.
·
The Journal of Urology
·
84
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
2024
·
Chris C Parker
, Noel W Clarke
, et al.
·
The Lancet
·
54
Asymptomatic microscopic or dipstick haematuria in adults: which investigations for which patients? A review of the evidence
2002
·
C. Tomson
, T. Porter
·
British Journal of Urology
·
53
Investigating the effect of erectile dysfunction on the lives of men: a qualitative research study
2002
·
DAVID PONTIN
, TIM PORTER
, et al.
·
Journal of Clinical Nursing
·
25
The ED-EQoL: The development of a new quality of life measure for patients with erectile dysfunction
2004
·
R.P. MacDonagh
, T. Porter
, et al.
·
Quality of Life Research
·
17
Endoscopic urethrotomy versus open urethroplasty for men with bulbar urethral stricture: the OPEN randomised trial cost-effectiveness analysis
2021
·
Jing Shen
, Luke Vale
, et al.
·
BMC Urology
·
8
PDF
On-treatment serum prostate-specific antigen and overall survival in prostate cancer (STAMPEDE platform protocol): a post-hoc analysis of data from five phase 3 trials
2026
·
Mahaz Kayani
, Laura Murphy
, et al.
·
The Lancet Oncology
·
7
PDF
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
2025
·
Gianmarco Leone
, Francesco Orlando
, et al.
·
JAMA Oncology
·
5
An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial
2026
·
Liam Bourke
, Derek J Rosario
, et al.
·
The Lancet Oncology
·
1
Surgery for pathological T3a, T3b and lymph node positive, prostate cancer: surgical, functional and oncological outcomes
2020
·
Niall Gilliland
, Sarath Vennam
, et al.
·
Journal of Clinical Urology
·
1
Erratum to “Book Review: Clinical Progress in Renal Cancer. Informa Healthcare, Tim Eisen, Tim Christmas (Eds.). (2007). 209 pp., ISBN: 10-284284-604X” [Surg. Oncol. 17 (2008) 59]
2008
·
Tim Porter
·
Surgical Oncology
Clinical Progress in Renal Cancer
2007
·
Tim Porter
·
Surgical Oncology
The Effect of Erectile Dysfunction on Quality of Life:
2002
·
RUARAIDH MacDONAGH
, PAUL EWINGS
, et al.
·
The Journal of Urology
Show more works
View as search
Works count:
14
Citation count:
375
H-index:
7
I10-index:
6
Year
Topic
Type